Accustem Sciences Inc.

0.4400

0.0000

成交量：416.00

成交額：183.67

市值：707.18萬

市盈率：- -

高：0.4400

開：0.4400

低：0.4400

收：0.4400

52周最高：2.33

52周最低：0.2525

股本：1,607.23萬

流通股本：992.21萬

量比：0.15

換手率：0.00%

股息：- -

股息率：- -

淨資產收益率：-1794.16%

總資產收益率：-120.29%

市淨率：-2.43

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Accustem Sciences Inc.與Emeritusdx攜手擴大血液檢測技術能力，推動癌症診斷與治療計劃發展

美股速递

·

2025/09/17

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACUT/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ACUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","market":"US","secType":"STK","nameCN":"Accustem Sciences Inc.","latestPrice":0.44,"timestamp":1772044200000,"preClose":0.44,"halted":0,"volume":416,"delay":15,"changeRate":0,"floatShares":9922079,"shares":16072267,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"02-25 13:30:00 EST 延時","open":0.44,"high":0.44,"low":0.44,"amount":183.67000288,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"adr":0,"exchange":"OTCQB","adjPreClose":0.44,"volumeRatio":0.154233},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","floatShares":9922079,"roa":"-120.29%","roe":"-1794.16%","lyrEps":0,"volumeRatio":0.154233,"shares":16072267,"dividePrice":0,"high":0.44,"amplitude":0,"preClose":0.44,"low":0.44,"week52Low":0.2525,"pbRate":"-2.43","week52High":2.33,"institutionHeld":0,"latestPrice":0.44,"eps":0,"divideRate":0,"volume":416,"delay":15,"open":0.44,"prevYearClose":0.81351,"prevWeekClose":0.4703,"prevMonthClose":0.6,"prevQuarterClose":0.8135,"fiveDayClose":0.4703,"twentyDayClose":0.5788,"sixtyDayClose":0.8256},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-16","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACUT\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146073182","title":"Accustem Sciences Inc.與Emeritusdx攜手擴大血液檢測技術能力，推動癌症診斷與治療計劃發展","url":"https://stock-news.laohu8.com/highlight/detail?id=1146073182","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146073182?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 19:01","pubTimestamp":1758106919,"startTime":"0","endTime":"0","summary":"Accustem Sciences Inc.与Emeritusdx携手扩大血液检测技术能力，推动癌症诊断与治疗计划发展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACUT"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}